Lung Cancer (NSCLC) Models

100+ NSCLC models in China Biobank, 11 in US Biobank. Multiple driver mutation subtypes: EGFR, KRAS, ALK, ROS1.

PDO 1.0 & 2.0

H&E, IHC, NGS

Validated Applications:

  • Targeted therapy efficacy by mutation subtype
  • Resistance mechanism studies
  • Immunotherapy evaluation